Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
TLR3 Antibody (40C1285.6) - BSA Free, Novus Biologicals™

Mouse Monoclonal Antibody has been used in 75 publications
Supplier: Novus Biologicals NBP224875
Description
TLR3 Monoclonal specifically detects TLR3 in Human, Mouse, Canine samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin, Flow (Intracellular), Bioactivity, Block/Neutralize.Specifications
TLR3 | |
Monoclonal | |
1.0 mg/mL | |
Western Blot 1-3 ug/ml, Flow Cytometry 2-4 ug/ 1x10^6 cells, Immunohistochemistry 1:10-1:500, Immunocytochemistry/Immunofluorescence 1:10-1:500, Immunoprecipitation 2 ug/ 1x10^6 cells, Immunohistochemistry-Paraffin 1:10-1:500, Flow (Intracellular) reported in scientific literature (PMID 24836676), Bioactivity reported in scientific literature (PMID 28894449), Block/Neutralize reported in scientific literature (PMID 28894449) | |
CD283, CD283 antigen, toll-like receptor 3 | |
Mouse | |
Protein G purified | |
RUO | |
Primary | |
This antibody is reactive to Dog, Human and Mouse. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
IgG1 κ |
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin), Neutralization | |
40C1285.6 | |
Unconjugated | |
O15455 | |
TLR3 | |
A synthetic peptide corresponding to amino acids 55-85 of human TLR3 was used as immunogen. | |
0.1 mg | |
Cytokine Research, Immune System Diseases, Immunology, Innate Immunity, Necroptosis, Signal Transduction, Toll Like Receptors | |
7098 | |
Human, Mouse, Canine | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction